Home

InfuSystems Holdings, Inc. Common Stock (INFU)

4.9100
-0.1200 (-2.39%)
NYSE · Last Trade: Apr 5th, 8:43 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Frequently Asked Questions About InfuSystems Holdings, Inc. Common Stock (INFU)

How does InfuSystems approach innovation?

InfuSystems actively invests in research and development to innovate its product lines and services. The company seeks to leverage technology and patient feedback to enhance user experiences, streamline processes, and introduce new solutions that address the evolving needs of healthcare providers and patients.

How does InfuSystems ensure product and service quality?

InfuSystems ensures quality through rigorous compliance with regulatory standards and certifications required by the healthcare industry. They implement quality assurance programs and continuously monitor their operations to maintain high standards for customer safety and satisfaction.

How does InfuSystems support the communities it serves?

InfuSystems supports the communities it serves through various initiatives, including providing education on infusion therapy, engaging in charitable contributions, and participating in community health events. Their efforts aim to promote awareness of infusion therapy and improve overall health outcomes.

How has InfuSystems responded to industry challenges?

InfuSystems has proactively responded to industry challenges by adapting its business model, enhancing service delivery, and leveraging technology to improve patient care. The company continuously monitors the healthcare landscape to ensure it meets the changing needs of its clients and complies with regulatory requirements.

Is InfuSystems publicly traded?

Yes, InfuSystems Holdings, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol 'INFU'. This allows the company to raise capital through public investments while offering shares to investors interested in participating in the healthcare sector.

What are InfuSystems' growth strategies?

InfuSystems' growth strategies involve expanding its service offerings, pursuing strategic acquisitions, and enhancing operational efficiencies. Additionally, the company is focusing on increasing its market share in existing and new therapeutic areas to drive overall revenue growth.

What are the primary products offered by InfuSystems?

InfuSystems offers a wide range of products including ambulatory infusion pumps, high-quality enteral feeding pumps, and a comprehensive suite of services such as patient education and technical support. Their infusion specialty products cater to oncology, pain management, and other therapeutic areas, enhancing the patients' experience and safety.

What areas of healthcare does InfuSystems focus on?

InfuSystems mainly focuses on oncology and pain management infusion therapies, but also provides solutions for other therapeutic areas requiring medication administration. Their specialization allows them to cater effectively to the distinct needs of patients with chronic illnesses and those requiring long-term therapies.

What does InfuSystems Holdings, Inc. do?

InfuSystems Holdings, Inc. is a leading provider of infusion therapy products and services in the United States, specializing in the provision of ambulatory infusion pumps and associated services for oncology, pain management, and other therapies. The company serves healthcare providers, patients, and the pharmaceutical industry, facilitating effective and safe medication administration.

What is InfuSystems' mission statement?

InfuSystems' mission is to provide the highest quality infusion therapy products and services in a cost-effective manner. They strive to enhance patient outcomes and experiences through innovation, operational excellence, and a commitment to exceptional customer service.

What is InfuSystems' revenue model?

InfuSystems operates on a revenue model that includes service revenue from rental and sales of infusion pump equipment, as well as related services such as maintenance and logistical support. The company also generates revenue through direct patient care services offered to healthcare providers and pharmaceutical partners.

What is the significance of InfuSystems' partnerships?

InfuSystems' partnerships with healthcare providers and pharmaceutical companies enhance its service offerings and expand its market reach. Collaborations allow for shared resources and knowledge, fostering innovation in infusion therapy and facilitating better patient outcomes.

What markets does InfuSystems serve?

InfuSystems serves a variety of markets within the healthcare sector across the United States, including hospitals, outpatient facilities, home healthcare organizations, and pharmaceutical companies. Their broad market reach positions them as a vital partner in providing infusion therapy services.

What recent developments have occurred within InfuSystems?

Recent developments within InfuSystems include strategic acquisitions intended to expand their service capabilities and enhance their product offerings. Additionally, they have focused on technological advancements to improve patient care and streamline operations in response to industry trends.

What regulatory bodies oversee InfuSystems' operations?

InfuSystems' operations are overseen by various regulatory bodies, including the U.S. Food and Drug Administration (FDA), which ensures compliance with safety and efficacy standards for medical devices. Additionally, the company adheres to regulations set forth by state health departments and other healthcare standards.

When was InfuSystems founded?

InfuSystems was founded in 2001, originally starting as a company focused on providing infusion pumps and support services. Over the years, it has expanded its product offerings and services, establishing itself as a key player in the healthcare sector, particularly in infusion therapy.

Where is InfuSystems headquartered?

InfuSystems is headquartered in Rochelle Park, New Jersey, where it operates its corporate functions along with its nationwide network of infusion services. This location supports the company’s logistics and operational efforts to deliver high-quality infusion therapies across the United States.

Who are InfuSystems' primary customers?

InfuSystems primarily serves healthcare providers, including hospitals, outpatient clinics, and home healthcare organizations. Additionally, their services cater to pharmaceutical companies and patients requiring ongoing infusion therapies, highlighting the company’s diverse customer base within the healthcare ecosystem.

Who are the members of InfuSystems' management team?

InfuSystems' management team comprises experienced professionals from various sectors of healthcare and business, including executives with backgrounds in operations, finance, and healthcare services. Their leadership drives the company's growth strategy and operational effectiveness.

What is the current price of InfuSystems Holdings, Inc. Common Stock?

The current price of InfuSystems Holdings, Inc. Common Stock is 4.910

When was InfuSystems Holdings, Inc. Common Stock last traded?

The last trade of InfuSystems Holdings, Inc. Common Stock was at 8:00 pm EDT on April 4th, 2025

What is the market capitalization of InfuSystems Holdings, Inc. Common Stock?

The market capitalization of InfuSystems Holdings, Inc. Common Stock is 100.99M

How many shares of InfuSystems Holdings, Inc. Common Stock are outstanding?

InfuSystems Holdings, Inc. Common Stock has 20.57M shares outstanding.